ReviewCurrent atherosclerosis reports2008
Exenatide as a treatment for diabetes and obesity: implications for cardiovascular risk reduction.
Derek D Mafong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it